Comprehending the spate of recent rejections in the cell and gene therapy space may require looking no further than ...
Phase 2 Data Highlight the Observed Abscopal-like Effect of VP-315 in Non-treated Basal Cell Carcinoma Tumors WEST CHESTER, Pa., May 05, 2026 ...
(Kateryna Kon/Science Photo Library/Getty Images) Chemotherapy and radiation have saved the lives of millions of children ...
Phase 2 Data Highlight the Observed Abscopal-like Effect of VP-315 in Non-treated Basal Cell Carcinoma Tumors WEST CHESTER, ...
Rokit Healthcare announced on May 6 that it will present clinical data on regenerative treatments for skin cancer at "EWMA ...
Getting life insurance after cancer depends on the cancer type, grade, treatment and timing ...
Scientists have developed an experimental wearable patch capable of destroying 97 percent melanoma tumors without surgical ...
First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical milestone on the path towards potential FDA ...
Sensus Healthcare (NASDAQ:SRTS) said its first quarter of 2026 marked a transition period as new dedicated CPT codes for ...
Certain dietary patterns may reduce symptom severity by reducing inflammation and modulating hormone levels. RDs with ...
The company’s latest performance highlighted improving same-center activity, expanding treatment categories, and stronger ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® ...